BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17466515)

  • 1. Analysis of population characteristics related to the total effective xenoestrogen burden: a biomarker of xenoestrogen exposure in breast cancer.
    Fernandez MF; Santa-Marina L; Ibarluzea JM; Exposito J; Aurrekoetxea JJ; Torne P; Laguna J; Rueda AI; Pedraza V; Olea N
    Eur J Cancer; 2007 May; 43(8):1290-9. PubMed ID: 17466515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk and the combined effect of environmental estrogens.
    Ibarluzea Jm Jm; Fernández MF; Santa-Marina L; Olea-Serrano MF; Rivas AM; Aurrekoetxea JJ; Expósito J; Lorenzo M; Torné P; Villalobos M; Pedraza V; Sasco AJ; Olea N
    Cancer Causes Control; 2004 Aug; 15(6):591-600. PubMed ID: 15280638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The total effective xenoestrogen burden, a biomarker of exposure to xenoestrogen mixtures, is predicted by the (anti)estrogenicity of its components.
    Fernandez MF; Aguilar-Garduño C; Molina-Molina JM; Arrebola JP; Olea N
    Reprod Toxicol; 2008 Sep; 26(1):8-12. PubMed ID: 18586082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the total effective xenoestrogen burden (TEXB) of breast cancer patients during an 18-month post-surgical follow-up.
    Fernandez MF; Pumarega J; Porta M; Molina-Molina JM; Arrebola JP; Olea N
    Reprod Toxicol; 2017 Apr; 69():212-220. PubMed ID: 28288811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the total effective xenoestrogen burden in extracts of human placentas.
    Lopez-Espinosa MJ; Silva E; Granada A; Molina-Molina JM; Fernandez MF; Aguilar-Garduño C; Olea-Serrano F; Kortenkamp A; Olea N
    Biomarkers; 2009 Aug; 14(5):271-7. PubMed ID: 19476411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of the total effective xenoestrogen burden (TEXB) in human adipose tissue. A pilot study.
    Arrebola JP; Fernandez MF; Molina-Molina JM; Martin-Olmedo P; Expósito J; Olea N
    Reprod Toxicol; 2012 Jan; 33(1):45-52. PubMed ID: 22107726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Effective Xenoestrogen Burden in Serum Samples and Risk for Breast Cancer in a Population-Based Multicase-Control Study in Spain.
    Pastor-Barriuso R; Fernández MF; Castaño-Vinyals G; Whelan D; Pérez-Gómez B; Llorca J; Villanueva CM; Guevara M; Molina-Molina JM; Artacho-Cordón F; Barriuso-Lapresa L; Tusquets I; Dierssen-Sotos T; Aragonés N; Olea N; Kogevinas M; Pollán M
    Environ Health Perspect; 2016 Oct; 124(10):1575-1582. PubMed ID: 27203080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Effective Xenoestrogen Burden in Serum Samples and Risk of Endometrial Cancer in the Spanish Screenwide Case-Control Study.
    Costas L; Frias-Gomez J; Peinado FM; Molina-Molina JM; Peremiquel-Trillas P; Paytubi S; Crous-Bou M; de Francisco J; Caño V; Benavente Y; Pelegrina B; Martínez JM; Pineda M; Brunet J; Matias-Guiu X; de Sanjosé S; Ponce J; Olea N; Alemany L; Fernández MF
    Environ Health Perspect; 2024 Feb; 132(2):27012. PubMed ID: 38415615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomonitoring of environmental estrogens in human tissues.
    Fernandez MF; Molina-Molina JM; Lopez-Espinosa MJ; Freire C; Campoy C; Ibarluzea J; Torne P; Pedraza V; Olea N
    Int J Hyg Environ Health; 2007 May; 210(3-4):429-32. PubMed ID: 17296326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male specific association between xenoestrogen levels in placenta and birthweight.
    Vilahur N; Molina-Molina JM; Bustamante M; Murcia M; Arrebola JP; Ballester F; Mendez MA; Garcia-Esteban R; Guxens M; Santa Marina L; Tardón A; Sunyer J; Olea N; Fernandez MF
    Environ Int; 2013 Jan; 51():174-81. PubMed ID: 23262415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
    Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.
    Yang XR; Pfeiffer RM; Garcia-Closas M; Rimm DL; Lissowska J; Brinton LA; Peplonska B; Hewitt SM; Cartun RW; Mandich D; Sasano H; Evans DB; Sutter TR; Sherman ME
    Cancer Res; 2007 Nov; 67(21):10608-17. PubMed ID: 17968031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero exposure to mixtures of xenoestrogens and child neuropsychological development.
    Vilahur N; Fernández MF; Bustamante M; Ramos R; Forns J; Ballester F; Murcia M; Riaño I; Ibarluzea J; Olea N; Sunyer J
    Environ Res; 2014 Oct; 134():98-104. PubMed ID: 25086706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective.
    Kortenkamp A
    Int J Androl; 2006 Feb; 29(1):193-8. PubMed ID: 16466540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenoestrogen concentration in women with endometriosis or leiomyomas: A case-control study.
    Valdes-Devesa V; Sanz-Rosa D; Thuissard-Vasallo IJ; Andreu-Vázquez C; Sainz de la Cuesta R
    PLoS One; 2024; 19(6):e0304766. PubMed ID: 38833439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The link between the insecticide heptachlor epoxide, estradiol, and breast cancer.
    Cassidy RA; Natarajan S; Vaughan GM
    Breast Cancer Res Treat; 2005 Mar; 90(1):55-64. PubMed ID: 15770527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
    Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
    BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D; Nielsen TO; Cheang MC; Foulkes WD
    Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.